Dawaa Reference

Clinical reference

Weight gain

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Cushing Syndrome - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK470218/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class TS06 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A very common, nonspecific presenting complaint; management depends entirely on identifying the cause (diet, low thyroid function, medication, Cushing's syndrome) rather than a direct prescription. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A very common, nonspecific presenting complaint; management depends entirely on identifying the cause (diet, low thyroid function, medication, Cushing's syndrome) rather than a direct prescription.

Cautions
  • Rapid weight gain with swelling and breathlessness may indicate heart failure or kidney disease; central weight gain with other features may indicate Cushing's syndrome.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.